Sorry, you need to enable JavaScript to visit this website.

Immunotechnologies for health

Characterization of mechanisms of immunoregulation to identify new therapeutic targets and disregulation underlying immune-mediated diseases (autoimmune, allergic, and inflammatory diseases).

  Through the integration of in vitro and in vivo models, experimental protocols and immunotherapeutic tools to treat cancer, to develop vaccines and to diagnose and treat chronic inflammatory diseases.

Molecular mechanisms in the pathogenesis of inflammatory diseases

Inflammation is the most common type of response that the body mounts when facing an assault from the surrounding environment. The inflammatory response occurs when tissues are injured by bacteria, trauma, toxins, heat, or any other cause. In this regard, the gastrointestinal tract is unique as it is permanently exposed to the external environment, it is constantly stimulated by a myriad of antigens and harbors the endogenous enteric flora.

Immunomodulatory activity of biological and biotecnological products of industrial relevance

In recent years, the development of new drugs benefits from the open innovation model that sees Research Institutions and industries to share skills and know-how. Immunology is one of the most interesting areas for biotech and pharmaceutical industries. ENEA has skills, knowledge and experimental models that can provide support to pharmaceutical companies and other industry stakeholders in the development of immunomodulatory drugs using and/or developing innovative assays shifted from basic research.